Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA extends market exclusivity for BioMarin’s Kuvan powder for oral solution and tablets
The FDA action extends KUVAN’s market exclusivity to June 2015 and is based on studies submitted in response to a written request by the FDA to investigate the
The FDA action extends KUVAN’s market exclusivity to June 2015 and is based on studies submitted in response to a written request by the FDA to investigate the
These cell banks are necessary steps in the production of the cells to be encapsulated using the cell-in-a-Box technology for Nuvilex’s Phase IIb clinical trials in advanced, inoperable
Xencor president and CEO Dr Bassil Dahiyat noted that Merck’s program is the sixth drug candidate using our XmAb intellectual property currently in clinical trials and is the
The newly issued patent claims a class of small molecule inhibitors of Rho-associated kinase (ROCK) that are crucial to the therapeutic application of human induced pluripotent stem cells
Duodopa is approved in Canada for the management of advanced Parkinson’s disease in adults with severe, disabling motor fluctuations and hyper-/dyskinesia (involuntary movements) not satisfactorily controlled by combinations
Assembly is developing novel drugs for the treatment and potential cure of chronic hepatitis B virus (HBV) infection. Johnson & Johnson, Twilight Ventures, Luson Bioventures and private investors
In May 2013, American CryoStem entered into a series of agreements with research scientists at Rutgers, The State University of New Jersey, including Dr KiBum Lee, Professor of
This agreement is another component of our slate of channel partners that we are strategically aligning ourselves with. Initially Menzer will focus on sales of our Ogiene products
Dr J. Tost’s team at CNG uses novel technologies to analyze gene regulation and epigenetics, specifically DNA methylation. DBV and CEA/CNG will collaborate to characterize the epigenetic modifications
Upset Stomach is the second variant to be launched in the F.A.S.T. range of products and it is formulated to relive upset stomach symptoms. It comes in a